Log in to save to my catalogue

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancrea...

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancrea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6241608

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ObjectiveExtensive molecular heterogeneity of pancreatic ductal adenocarcinoma (PDA), few effective therapies and high mortality make this disease a prime model for advancing development of tailored therapies. The p16-cyclin D-cyclin-dependent kinase 4/6-retinoblastoma (RB) protein (CDK4) pathway, regulator of cell proliferation, is deregulated in...

Alternative Titles

Full title

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6241608

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6241608

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2017-315144

How to access this item